Plamotamab

plamotamab · Xencor, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Plamotamab, covering 2024-04-30 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b Open-label Study to Evaluate Safety of Plamotamab in Participants With Rheumatoid Arthritis [Phase 1]